Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
چکیده
The Society of Gynecologic Oncology's (“SGO”) Clinical Practice Committee has developed a series of Clinical Documents designed to improve the overall quality of women's cancer care; reduce the use of unnecessary, ineffective or harmful interventions; as well as facilitate the optimal treatment of patients with a goal to maximize the therapeutic benefit, and minimize the risk of harm, at acceptable cost. In developing clinical documents, SGO follows a rigorous process to assure that any conflicts of interest are disclosed and appropriately addressed and that relationships with manufacturers and other third parties do not influence the development process. More specifically, SGO adheres to the principles adopted by the Council of Medical Specialty Societies (“CMSS”) in developing, adopting and promulgating clinical guidelines and consensus statements. Consistent with CMSS principles, SGO received no funding from any manufacturer to support the development of this Consensus Statement nor any other clinical consensus statement or practice guideline developed and published by SGO. In accordance with CMSS principles, SGO requires that its clinical documents be subject to multiple levels of review beginning with a review by SGO's full Clinical Practice Committee. After review and approval by the Clinical Practice Committee, Consensus Statements are submitted to the SGO Council which is SGO's governing body which reviewed and approved the Consensus Statement for submission to SGO's Journal. None of the members of the SGO Council has a financial or other relationship with Intuitive. In accordance with those principles, each member of the Robotics Clinical Task Forcewhich developed the Consensus Statement executed a detailed disclosure statement prior to participating in the Task Force. There is currently only one manufacturer of robotic gynecology technology, Intuitive Surgical Inc., of Sunnyvale, California (“Intuitive”). Onemember of the thirteenmembers of the Robotics Clinical Task Force has a consulting relationship with Intuitive and receives honoraria from Intuitive for teaching advanced courses at his institution. SGO has received unrestricted educational grants from Intuitive to provide educational support for its annual and winter meetings at approximately $25,000 a year over 5 years. All content for these educational programs was developed in accordance with ACCME standards. Clinical Documents are intended to be educational devices that provide information that may assist healthcare providers in caring for patients. This Clinical Document is not a rule and should not be construed as establishing a legal standard of care or as encouraging,